Latest Breaking News On - Head global business development - Page 3 : comparemela.com
Week at a glance: News ops in COVID times; Spotlight on PR; Performance marketing
adgully.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from adgully.com Daily Mail and Mail on Sunday newspapers.
Uday Sodhi, Jasmeet Singh & Manish Agarwal partner for Founder s Room Capital
adgully.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from adgully.com Daily Mail and Mail on Sunday newspapers.
This oncologic clinical trial evaluates the efficacy and safety of the CDK 4/6 Inhibitor Abemaciclib in combination with endocrine therapy in high-risk early breast cancer patients
Cologne, Germany, 07.01.2021 – CANKADO, the leading digital health application developers in Germany, assists the recently started clinical trial, ADAPTlate, organized by West German Study Group (WSG) to collect the Patient Reported Outcomes (PROs) by the CANKADO ePRO tool. The clinical trial already enrolled the first patients who are using the CANKADO e-Health system as part of the study to monitor their Quality of Life (QoL). The trial aims to gain further knowledge on the efficacy and safety of the Abemaciclib treatment in combination with endocrine therapy versus standard endocrine therapy in HR+/HER2- early breast cancer patients with high risk for disease recurrence.
The tool is a drug tailored extension of CANKADO’s e-Health solution
Cologne, Germany, 17.12.2020 – CANKADO’s Companion-APP solution provides an environment that helps to build a drug-tailored digital connected care solution for physicians and their patients. Pharmaceutical companies can easily develop their own multi-dimensional drug-optimized digital support for every drug and treatment. It improves patient safety, increases patient compliance, and prolongs drug adherence for a better outcome. CANKADO Companion-APP is a complete solution comprising a family of medical devices according to EU and US regulations. It is built on CANKADO’s backbone structure that consists of patient’s records ensuring data security and privacy. It allows connection to healthcare professionals and includes the AI-driven PRO-React framework. Information extensions are integrated on Companion-APP, tailored for each drug/treatment. Pharma partners of CANKADO can build their own drug tailore
WSG and CANKADO s EnReP predicts the benefits of anti-hormone
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.